Lobe Sciences Ltd.
LOBEF
$0.027
-$0.0005-1.82%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | -- | -- | 99.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | -- | -- | 99.80K |
| Cost of Revenue | -- | 11.20K | -- | -- | 1.30K |
| Gross Profit | -- | -11.20K | -- | -- | 98.50K |
| SG&A Expenses | 461.20K | 283.70K | 280.50K | 402.30K | 343.00K |
| Depreciation & Amortization | -- | 0.00 | 20.70K | 21.00K | 20.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 466.70K | 295.70K | 433.20K | 435.30K | 503.60K |
| Operating Income | -466.70K | -295.70K | -433.20K | -435.30K | -403.80K |
| Income Before Tax | -582.00K | -2.04M | -313.20K | -443.20K | -416.00K |
| Income Tax Expenses | -- | 24.10K | -- | -- | -- |
| Earnings from Continuing Operations | -582.00K | -2.07M | -313.20K | -443.20K | -416.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -582.00K | -2.07M | -313.20K | -443.20K | -416.00K |
| EBIT | -466.70K | -295.70K | -433.20K | -435.30K | -403.80K |
| EBITDA | -451.30K | -295.70K | -412.50K | -414.30K | -383.10K |
| EPS Basic | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 173.70M | 170.91M | 158.77M | 79.14M | 79.14M |
| Average Diluted Shares Outstanding | 173.70M | 170.91M | 158.77M | 79.14M | 79.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |